• Gust Logo
  • AngelList Logo
  • StartHub Boston Logo
  • AngelMD Logo

Our Development

The urinary catheter market is stagnated and ready for our disruption

Research

Initial tests of the PSM urinary catheter yielded a reduction in bacterial growth. It has the potential to significantly reduce the risk of CAUTIs in catheterized patients.

Analysis

CAUTI reduction is the goal. Therapeutic delivery system is what's possible. Analysis and data to be submitted for 510(k) clearance with the Food and Drug Administration.

Development

Affordable. Disposable. Innovative.
We live by this and are developing a product to push the limits of a simple product that solves a large problem.
Find out more about drug delivery systems.

Our Why

Our Why

  • We care about reducing infections
  • We care about vulnerable patients
  • We care about quality of care

The Statistics

  • According to CDC, >560,000 Catheter-Associated Urinary Tract Infections (CAUTIs) annually with a cost to the facility on average of $1,007 per case
  • Classified as a "Never Event" by CMS with many insurers not reimbursing if UTI is within 7 days of being catheterized
  • 25% of all hospitalized patients receive an indwelling catheter
  • Chance of infection increases 9% per day (compounding) when the catheter is in place
  • CAUTI composes 40% of all healthcare-associated infections (HAIs)
  • In extended use, patients are 3 times more likely to die
  • Catheter design has not changed much since 1935

"CAUTI can relate to $1,007 in unreimbursed spending per event."

(Scott, 2009)

Our Team

Francisco Portela, RN
Francisco Portela, RN
Founder & CEO
Amit Soni
Amit Soni
Founder & Chief Operating Officer
Kenneth Kim
Kenneth Kim
Chief Scientific Officer
Juan Portela
Juan Portela
Lead Biomedical Engineer
David Berger, Esq.
David Berger, Esq.
General Counsel
Stephanie Lee
Stephanie Lee
Project Manager
Alan Poon
Alan Poon
Biomedical Engineer
JP Lalumia
JP Lalumia
Project Manager
Sarah Dulaney
Sarah Dulaney
Marketing Technology Manager
Don Malackowski
Don Malackowski
Advisor
John Janik, PhD
John Janik, PhD
Advisor
Joseph Renzulli II, MD
Joseph Renzulli II, MD
Medical Officer
Gyan Pareek, MD
Gyan Pareek, MD
Medical Officer
Lori Escallier, PhD, RN, CPNP-PC
Lori Escallier, PhD, RN, CPNP-PC
Advisor
Vrad Levering, PhD
Vrad Levering, PhD
Advisor
Stephen Laddy, MS, R.Ph.
Stephen Laddy, MS, R.Ph.
Advisor
Constance Howes, J.D., Esq., FACHE
Constance Howes, J.D., Esq., FACHE
Advisor
Eamonn Hobbs
Eamonn Hobbs
Advisor

Patient Stories

"Urinary tract infection (UTI) is one of the most common hospital-acquired infections; 70%-80% of these infections are attributable to an indwelling urethral catheter."

(Lo et. al, 2014)

Partners

  • SproutRI Logo
  • MedMates logo
  • SE Greenhouse logo
  • Warner & Co LLC Logo

Share With Us

Do you have a real story where you had a catheter placed and had a poor outcome or experience? We want to know.

Submit your story to us so that we can continue to work on a problem that matters to you.


  • medgadget logo
  • science news logo
  • AUAnet logo
  • NIH logo

Connect With Us

"At this point the evidence is insufficient to recommend the following potential alternatives to indwelling urinary catheters as a means to prevent CAUTI: antimicrobial catheters, intermittent catheterization, suprapubic catheters, and condom catheters."

(Trautner, 2011)